Third Military Medical University - Army Medical University Reports Findings in Lung Cancer (Integrated multi-omics and machine learning reveal a gefitinib resi stance signature for prognosis and treatment response in lung adenocarcinoma)

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Oncology - Lung Cancer is the subject of a report. According to newsoriginating from Chongqing, Peopl e’s Republic of China, by NewsRx correspondents, research stated,“Gefitinib res istance (GR) presents a significant challenge in treating lung adenocarcinoma (L UAD),highlighting the need for alternative therapies. This study explores the g enetic basis of GR to improveprediction, prevention, and treatment strategies.”

外文关键词：

ChongqingPeople’s Republic of ChinaA siaAdenocarcinomaAntineoplasticsCancerCyborgsDrugs and TherapiesEGFR InhibitorsEmerging TechnologiesGefitinib TherapyGeneticsHealth and Medi cineImmunotherapyLung CancerLung Diseases and ConditionsMachine LearningOncologyPharmaceuticalsTyrosine Kinase Inhibitors

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Dec.13)